ATTILI, ILARIA

ATTILI, ILARIA  

Università di Padova  

Mostra records
Risultati 1 - 13 di 13 (tempo di esecuzione: 0.025 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): Does biological rationale meet clinical needs? 2017 ATTILI, ILARIAPAVAN, ALBERTOCONTE, PIERFRANCO + CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - -
Therapeutic approaches for T790M mutation positive non-small-cell lung cancer 2018 Attili, IlariaConte, PierFranco + EXPERT REVIEW OF ANTICANCER THERAPY - -
The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes 2018 Bonanno, L.PAVAN, ALBERTODieci, M. V.DI LISO, ELISABETTASchiavon, M.COMACCHIO, GIOVANNI MARIAATTILI, ILARIAPasello, G.Calabrese, F.Rea, F.Favaretto, A.Rugge, M.Guarneri, V.Fassan, M.Conte, P. F. EUROPEAN JOURNAL OF CANCER - -
Immunotherapy in SCLC: Exceptional Clinical Benefit and Abscopal Pneumonitis After Radiotherapy 2019 Attili I.Pasello G.Guarneri V. + JOURNAL OF THORACIC ONCOLOGY - -
LKB1 and tumor metabolism: The interplay of immune and angiogenic microenvironment in lung cancer 2019 Pavan A.Attili I.Pasello G.Conte P.Indraccolo S. + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
Potentialities of liquid biopsy in advanced non-small cell lung cancer (aNSCLC): Early evaluation of sentinel mutations in plasma and outcome of patients treated with immunotherapy 2019 Zulato, E.Attili, I.Del Bianco, P.Nardo, G.Boscolo Bragadin, A.Pasqualini, L.Calabrese, F.Fassan, M.Pasello, G.Guarneri, V.Conte, P.Indraccolo, S. + ANNALS OF ONCOLOGY - -
Immunotherapy in small-cell lung cancer: From molecular promises to clinical challenges 2019 Pavan A.Attili I.Pasello G.Guarneri V.Conte P. F. + JOURNAL FOR IMMUNOTHERAPY OF CANCER - -
Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors 2019 Pavan A.Dal Maso A.Attili I.Pasello G.Guarneri V.Conte P. + THE ONCOLOGIST - -
Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancer 2020 Pasello G.Attili I.Menis J.Conte P.Guarneri V. + CANCER TREATMENT REVIEWS - -
SRC and PIM1 as potential co-targets to overcome resistance in MET deregulated non-small cell lung cancer 2020 Attili I.Maso A. D.Fassan M.Pasello G.Guarneri V.Conte P. F. + TRANSLATIONAL LUNG CANCER RESEARCH - -
Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome 2020 Zulato, ElisabettaFerro, AlessandraBoscolo, AliceAttili, IlariaFrega, StefanoDal Maso, AlessandroPasello, GiuliaGuarneri, ValentinaConte, Pier FrancoIndraccolo, Stefano + JOURNAL OF CLINICAL ONCOLOGY - -
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer 2020 Zulato, ElisabettaAttili, IlariaPavan, AlbertoDel Bianco, PaolaBoscolo Bragadin, AndreaPasello, GiuliaFassan, MatteoCalabrese, FiorellaGuarneri, ValentinaAmadori, AlbertoConte, PierFrancoIndraccolo, Stefano + BRITISH JOURNAL OF CANCER - -
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome 2021 Boscolo Bragadin, AndreaZulato, ElisabettaAttili, IlariaDal Maso, AlessandroFrega, StefanoFassan, MatteoCalabrese, FiorellaPasello, GiuliaGuarneri, ValentinaConte, PierFrancoIndraccolo, Stefano + TRANSLATIONAL LUNG CANCER RESEARCH - -